Lanzhou University Second Hospital
Clinical trials sponsored by Lanzhou University Second Hospital, explained in plain language.
-
New radioactive therapy shows promise for Hard-to-Treat cancers
Disease control CompletedThis early-phase study tested a new radioactive drug called 177Lu-CTR-FAPI in 12 people with advanced solid tumors (breast, sarcoma, thyroid) that had spread and no longer responded to standard treatments. The main goal was to check if the drug is safe and how it spreads in the b…
Phase: EARLY_PHASE1 • Sponsor: Lanzhou University Second Hospital • Aim: Disease control
Last updated May 25, 2026 19:31 UTC
-
New radioactive drug shows promise for Hard-to-Treat cancers
Disease control CompletedThis study tested a new radioactive drug called [177Lu]Lu-TEFAPI-06 in 5 people with advanced solid tumors that had spread and were not responding to standard treatments. The goal was to see if the drug is safe and how it spreads in the body. Researchers also looked at whether it…
Phase: EARLY_PHASE1 • Sponsor: Lanzhou University Second Hospital • Aim: Disease control
Last updated May 15, 2026 11:55 UTC